Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a -17.918% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
(a) N#C/C(=C\c1ccc2c(c1)OCO2)C(=O)N1CCOCC1
(b) Cc1nc(C(Cl)(Cl)Cl)nc2[nH]ccc(=O)c12
(c) O=C(NC1=NCCS1)c1ccc(N2CCCC2=O)cc1
Answer: a. N#C/C(=C\c1ccc2c(c1)OCO2)C(=O)N1CCOCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
N#C/C(=C\c1ccc2c(c1)OCO2)C(=O)N1CCOCC1
N#C/C(=C\c1ccc2c(c1)OCO2)C(=O)N1CCOCC1
(E)-3-(1,3-benzodioxol-5-yl)-2-(morpholine-4-carbonyl)prop-2-enenitrile